We report here for the first time the establishment and characterization of tumor xenograft mouse models with predefined HER2 and/or EGFR expression, and demonstrate that [64Cu]Cu-NOTA-trastuzumab Fab-PEG24-EGF bsRICs were able to exploit receptor heterogeneity for tumor imaging by PET. This evidence concerns the gene EGF and neoplasm.